- No file added yet -

Safety Evaluation of Recombinant Fusion Protein RP22 as a Skin Test Reagent for Tuberculosis Diagnosis: A PhaseⅠClinical Trial

media

posted on 2021-04-06, 13:45 authored by Lu Xia, Xu-hui Liu, Zhang-yan Zhao, Tao Li, Xiu-hong Xi, Ping Liu, Wei Huang, Xiao-yong Fan, Xue-qiong Wu, Shui-hua Lu

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).